Accessibility Menu
Arcadia Biosciences logo

Arcadia Biosciences(NASDAQ) RKDA

Current Price$0.62
Market Cap$1.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-99%
1 Year-85%
1 Month-16%
Arcadia Biosciences last closing stock price
MetricPriceDate
Last closeUSD 0.652026-07-22
Arcadia Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.66%USD 0.662026-07-15
1 month-15.8%USD 0.772026-06-22
3 month-38.68%USD 1.062026-04-23
Year to date-67.17%USD 1.982025-12-31
1 year-84.92%USD 4.312025-07-22
3 year-88.03%USD 5.432023-07-21
5 year-99.32%USD 95.102021-07-23
Since inception-99.99%USD 5,840.002015-05-15

Arcadia Biosciences Financials at a Glance

Market Cap

$1.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.76M

Net Income (TTM)

-$9.32M

EPS (TTM)

-$5.72

P/E Ratio

-0.12

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$0.62

Volume

324

Open

$0.62

Previous Close

$0.62

Daily Range

$0.62 - $0.62

52-Week Range

$0.59 - $6.71

Estimated Earnings Date

Aug 19, 2026

RKDA News

Foolcom-Featured.png

Arcadia Biosciences Sales Up 11 Percent

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arcadia Biosciences

Zola coconut water from Arcadia helps people stay hydrated with low-calorie drinks. The company focuses on plant-based beverages for health-conscious consumers. Its products are sold in U.S. grocery stores and foodservice outlets.

What’s in the Cart? Arcadia’s Products at a Glance

  • Zola Coconut Water: Plant-based beverage, 100% of 2025 revenue, sold in U.S. grocery and foodservice channels.
  • Flavored Coconut Water: Includes Original, Original with Pulp, Espresso, and Pineapple, targeting consumers seeking variety.
  • Discontinued Brands: GoodWheat and GLA oil, no longer contributing to revenue after 2024 asset sales.

Plot Twists: Growth Moves and Strategic Shifts

  • Exited wheat trait and GoodWheat businesses in 2024, selling assets to Corteva and Above Food.
  • Sold patent portfolios to Bioceres Crop Solutions in March 2025.
  • Terminated planned business combination with Roosevelt Resources LP in December 2025.
  • Shifted focus to a single beverage product line by 2025.

Why Arcadia Isn’t Just Another Beverage Brand

Arcadia sources coconuts directly from Thailand, packaging at origin for freshness. Its Zola coconut water is Non-GMO Project Verified and low-calorie. The company relies on established U.S. distribution networks for market access.

Five Things You Need to Know

  • 2025 revenue was $4.86 million, down 4% from 2024.
  • Gross profit margin was about 36% in 2025.
  • Net loss from continuing operations improved to $(2.34) million in 2025.
  • Four customers made up 60% of 2025 revenue, showing high concentration risk.
  • Cash and equivalents fell to $259,000 at year-end 2025, raising liquidity concerns.

Bottom Line

Arcadia has transformed from an agri-biotech firm to a focused beverage company. Its future depends on Zola coconut water and managing operational risks.

AI Generated • Apr 16, 2026

Industry

Food Products

Sector

Consumer Staples

Employees

8

CEO

Thomas J. Schaefer, CFA, MBA

Website

www.arcadiabio.com

Headquarters

Davis, TX 95618, US

RKDA Financials

Key Financial Metrics (TTM)

Gross Margin

34.49%

Operating Margin

-200.78%

Net Income Margin

-195.94%

Return on Equity

-219.35%

Return on Capital

-241.43%

Return on Assets

-175.15%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.18M

Volume

324

Avg. Volume

3.09M

Financials (TTM)

Gross Profit

$1.64M

Operating Income

-$9.55M

EBITDA

-$9.29M

Operating Cash Flow

-$4.25M

Capital Expenditure

$0.00

Free Cash Flow

-$4.25M

Cash & ST Invst.

$3.72M

Total Debt

$0.00

Arcadia Biosciences Performance Analysis

Arcadia Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,418,0009.4%
20232023-12-31USD 4,454,000-40.0%
20242024-12-31USD 5,045,00013.3%
20252025-12-31USD 4,858,000-3.7%
Arcadia Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3021.3%
Q32025-09-30-10.5%
Q42025-12-31-30.8%
Q12026-03-3122.1%
Arcadia Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -25.65-6.9%
20232023-12-31USD -11.30-55.9%
20242024-12-31USD -5.16-54.3%
20252025-12-31USD -1.71-66.9%
Arcadia Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-271.6%
Q32025-09-30119.0%
Q42025-12-31-258.1%
Q12026-03-31-227.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.10M

-8.3%

Gross Profit

$400.00K

-22.8%

Gross Margin

36.36%

N/A

Market Cap

$1.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$183.95K

N/A

Employees

8

N/A

Net Income

-$4.39M

-268.7%

EBITDA

-$4.38M

-267.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$3.72M

+17.8%

Total Debt

$0.00

-100.0%

Accounts Receivable

$425.00K

-88.1%

Inventory

$840.00K

-34.6%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.75%

N/A

Return on Invested Capital

-2.41%

N/A

Free Cash Flow

-$1.10M

+30.8%

Operating Cash Flow

-$1.10M

+30.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAPSCapstone Holding Corp.
$0.24-3.29%
CNEYCN Energy Group. Inc.
$0.65+2.73%
RETOReTo Eco-Solutions, Inc.
$2.81-1.58%
ENFYEnlightify Inc.
$0.02+258.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
ONDSOndas
$8.00+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%

Questions About RKDA

What is the current price of Arcadia Biosciences?

Arcadia Biosciences is trading at $0.62 per share.

What is the 52-week range for Arcadia Biosciences?

Over the past 52 weeks, Arcadia Biosciences has traded between $0.59 and $6.71.

How much debt does Arcadia Biosciences have?

As of the most recent reporting period, Arcadia Biosciences reported total debt of $0.00.

How much cash does Arcadia Biosciences have on hand?

Arcadia Biosciences reported $954.00K in cash and cash equivalents in its most recent financial results.

What is Arcadia Biosciences’s dividend yield?

Arcadia Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services